Wouldn't say heavily experienced using Bisantrene but they know it very well + well respected in treating AML and regularly are working on treating patients with AML. I guess to a degree the concern (Hence not a complete gamechanger) is how quickly are they moving away from Chemo treatment. As I said, they had very good things to say about this investment and that it is better than current treatments. Anymore and I will be revealing the person. My medical field is outside this scope.
RAC - Charts & Price Action, page-1450
-
- There are more pages in this discussion • 20,753 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.68 |
Change
0.050(3.08%) |
Mkt cap ! $285.4M | |||
| Open | High | Low | Value | Volume |
| $1.65 | $1.75 | $1.64 | $210.4K | 125.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | $1.65 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 595 | 1 |
View Market Depth
| Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |